The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Doused in Denmark

Doused in Denmark

August 1, 2009 • By David S. Pisetsky, MD, PhD

  • Tweet
  • Email
Print-Friendly Version / Save PDF
David S. Pisetsky, MD, PhD

If any doubt about the growth of rheumatology worldwide still lingered, the European League Against Rheumatism (EULAR) congress in Copenhagen this June should have ended it. The meeting was not just big. It was gigantic and filled the sleek new Bella Center on the outskirts of the city. On the grounds of the Bella Center sits a large wind turbine which, while generating the nice green electricity, looked as if it was blowing hoards of rheumatologists through the entrance doors, jetting them into lecture halls and exhibit areas.

You Might Also Like
  • Experiencing EULAR: An ARHP Perspective
  • Medical Renaissance
  • An American in Paris
Explore This Issue
August 2009
Also By This Author
  • Top Research in Axial Spondyloarthritis Presented at ACR Convergence 2022

The crowding magnified the impression of the meeting’s size. The wide corridors were jammed with people who seemed relentlessly hungry for knowledge. Even in the caverns of the big auditoriums, the sessions were standing room only. On more than one occasion, I had to watch a lecture on a TV monitor outside a barricaded room assiduously guarded by a security officer, albeit a pleasant young woman.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE
Doused in Denmark

Soggy City

While the record number of attendees led to crowding, the weather was also a big factor keeping people inside the convention center. For the first four days I was there, rain pelted wonderful, wonderful Copenhagen and a fierce wind blasted fusillades of water across the city. We learned later that this was the wettest week in Copenhagen history and one day saw the ninth largest rain accumulation ever recorded in Denmark. People making their way from the subways arrived at the Bella Center drenched, their umbrellas blown apart in cyclonic winds.

I do not know what Danes call this weather, but in the United States, it would be a nor’ easter, although someone said it was like Katrina. With the weather preventing sightseeing and the only attraction around the Bella Center the wind turbine (and how many times can you watch it go around?), people probably logged a record number of CME hours. While standing during a session in a hot, densely packed lecture room, I turned to a friend and suggested that the best way to clear out the place would be to run down the aisle yelling, “The sun is shining, the sun is shining!” The stampede out the door would have been downright dangerous, although I would have finally gotten a seat.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Although the rain dampened the usual excitement of a meeting in a great capital of Europe— indeed, a beautiful gal of a town—I had many vivid impressions of EULAR. I anticipate that the ACR annual meeting in Philadelphia will reprise and amplify these themes.

A meeting with the climatic vicissitudes of the 2009 EULAR congress can’t help but inspire metaphors to describe the state of our specialty. I asked myself “What is the real rheumatology today?”

Plenty to Discuss for Rheumatology

Certainly, as many talks and posters demonstrated, therapy for inflammatory disease is advancing rapidly. Whether a speaker cited remission rates of 50% in the treatment of rheumatoid arthritis (RA) or described new agents to block diseases mediated by interleukin-1, the progress remains very impressive. As treatment moves forward, challenging questions will arise. Can patients in RA in remission stop their DMARDs (any or all)? If they stop therapy and relapse, can remission be recaptured? These are exciting new topics for inquiry that should provide a rich research agenda for the coming years.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Pages: 1 2 3 | Single Page

Filed Under: Opinion, Rheuminations Tagged With: Annual Meeting, Disease, DMARDs, EULAR, Rheumatoid arthritis, TravelIssue: August 2009

You Might Also Like:
  • Experiencing EULAR: An ARHP Perspective
  • Medical Renaissance
  • An American in Paris
  • EULAR Magic

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)